Index DJIA, S&P 500
P/E 14.94
EPS (ttm) 10.87
Insider Own 0.03%
Shs Outstand 1.87B
Perf Week -2.42%
Market Cap 299.11B
Forward P/E 11.47
EPS next Y 14.16
Insider Trans -2.34%
Shs Float 1.84B
Perf Month 0.43%
Income 20.30B
PEG 3.14
EPS next Q 3.35
Inst Own 73.99%
Short Float 2.83%
Perf Quarter 6.55%
Sales 195.02B
P/S 1.53
EPS this Y -1.26%
Inst Trans -0.69%
Short Ratio 6.39
Perf Half Y 9.10%
Book/sh 86.96
P/B 1.87
EPS next Y 9.19%
ROA 7.84%
Short Interest 52.15M
Perf Year 3.89%
Cash/sh 3.48
P/C 46.70
EPS next 5Y 4.75%
ROE 12.68%
52W Range 139.62 - 171.70
Perf YTD 8.81%
Dividend Est. 6.54 (4.03%)
P/FCF 15.62
EPS past 5Y 7.97%
ROI 11.14%
52W High -5.47%
Beta 1.11
Dividend TTM 6.16 (3.80%)
Quick Ratio 0.93
Sales past 5Y 11.17%
Gross Margin 16.98%
52W Low 16.24%
ATR (14) 2.93
Dividend Ex-Date May 16, 2024
Current Ratio 1.23
EPS Y/Y TTM -41.30%
Oper. Margin 12.49%
RSI (14) 55.59
Volatility 2.07% 1.85%
Employees 45600
Debt/Eq 0.14
Sales Y/Y TTM -15.98%
Profit Margin 10.41%
Recom 1.81
Target Price 182.99
Option/Short Yes / Yes
LT Debt/Eq 0.13
EPS Q/Q -13.99%
Payout 53.14%
Rel Volume 1.02
Prev Close 160.25
Sales Surprise 0.61%
EPS Surprise 0.33%
Sales Q/Q -4.50%
Earnings Apr 26 BMO
Avg Volume 8.16M
Price 162.30
SMA20 0.73%
SMA50 3.25%
SMA200 4.49%
Trades
Volume 8,430,277
Change 1.28%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-29-24 Reiterated
TD Cowen
Hold
$155 → $160
Apr-11-24 Upgrade
Scotiabank
Sector Perform → Sector Outperform
$195
Apr-10-24 Initiated
Barclays
Overweight
$203
Feb-06-24 Downgrade
DZ Bank
Buy → Hold
$160
Jan-23-24 Downgrade
TD Cowen
Outperform → Market Perform
$170 → $150
Jan-16-24 Downgrade
Scotiabank
Sector Outperform → Sector Perform
Jan-08-24 Upgrade
Jefferies
Hold → Buy
$184
Nov-02-23 Upgrade
Bernstein
Mkt Perform → Outperform
$184 → $182
Oct-30-23 Upgrade
BofA Securities
Neutral → Buy
$190 → $200
Oct-17-23 Initiated
Bernstein
Mkt Perform
$184
Oct-12-23 Upgrade
Exane BNP Paribas
Neutral → Outperform
$190
Aug-16-23 Upgrade
Mizuho
Neutral → Buy
$205 → $209
Jul-31-23 Upgrade
Goldman
Neutral → Buy
$187
Jun-01-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$165 → $180
May-31-23 Upgrade
JP Morgan
Underweight → Neutral
$161 → $170
May-23-23 Upgrade
HSBC Securities
Hold → Buy
$189
Apr-19-23 Initiated
UBS
Buy
$212
Apr-13-23 Upgrade
Scotiabank
Sector Perform → Sector Outperform
$195 → $200
Apr-04-23 Upgrade
Exane BNP Paribas
Underperform → Neutral
$200
Jan-10-23 Downgrade
Mizuho
Buy → Neutral
$185 → $200
Show Previous Ratings
Today 07:15AM
02:45AM
May-06-24 04:36PM
03:42PM
01:47PM
01:43PM
Loading…
01:43PM
12:42PM
11:47AM
11:13AM
08:45AM
06:00AM
May-04-24 03:31AM
May-03-24 03:17PM
06:54AM
06:25AM
04:41AM
Loading…
04:41AM
01:04AM
May-02-24 12:20PM
12:18PM
10:12AM
05:50AM
04:44AM
03:55AM
(Associated Press Finance)
May-01-24 04:01PM
(Investor's Business Daily)
02:08PM
01:30PM
12:45PM
12:02PM
08:33AM
06:00AM
04:27AM
Loading…
04:27AM
03:15AM
Apr-30-24 05:02PM
(Investor's Business Daily)
04:48PM
04:25PM
01:41PM
12:05PM
12:00PM
10:00AM
09:00AM
08:30AM
(Investor's Business Daily)
07:37AM
06:32AM
06:00AM
Apr-29-24 06:05PM
06:00PM
05:24PM
04:44PM
04:09PM
03:50PM
03:04PM
01:05PM
01:00PM
12:06PM
11:14AM
10:34AM
(Investor's Business Daily)
08:31AM
06:03AM
03:36AM
03:00AM
Apr-28-24 06:54PM
06:49PM
06:40PM
11:32AM
10:57AM
03:35AM
Apr-27-24 05:59PM
10:25AM
09:00AM
09:00AM
08:48AM
06:00AM
06:00AM
03:16AM
01:20AM
(Thomson Reuters StreetEvents)
Apr-26-24 05:37PM
(The Wall Street Journal)
05:20PM
04:59PM
04:08PM
04:02PM
(Investor's Business Daily)
04:00PM
03:06PM
02:10PM
01:10PM
01:02PM
01:02PM
12:24PM
11:08AM
11:07AM
10:56AM
10:53AM
10:46AM
(The Wall Street Journal)
10:33AM
(The Wall Street Journal)
10:20AM
09:56AM
09:55AM
(Investor's Business Daily)
09:33AM
09:14AM
09:14AM
09:04AM
Chevron Corp. engages in the provision of administrative, financial management, and technology support for energy and chemical operations. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded in 1906 and is headquartered in San Ramon, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
HERNANDEZ ENRIQUE JR Director May 06 '24 Sale 163.50 5,098 833,523 2,549 May 06 06:32 PM HERNANDEZ ENRIQUE JR Director May 02 '24 Sale 161.00 2,549 410,389 7,647 May 06 06:32 PM Knowles Alana K VP and Controller Apr 25 '24 Option Exercise 110.37 2,800 309,036 3,076 Apr 29 04:39 PM Knowles Alana K VP and Controller Apr 25 '24 Sale 165.00 2,800 462,000 276 Apr 29 04:39 PM Knowles Alana K VP and Controller Apr 02 '24 Option Exercise 110.37 2,800 309,036 3,076 Apr 04 08:05 PM Knowles Alana K VP and Controller Apr 02 '24 Sale 160.09 2,800 448,252 276 Apr 04 08:05 PM Knowles Alana K VP and Controller Jan 31 '24 Option Exercise 0.00 1,668 0 3,060 Feb 02 06:50 PM MORRIS RHONDA J Vice President Jan 31 '24 Option Exercise 0.00 11,152 0 11,481 Feb 02 06:38 PM Krishnamurthy Balaji Vice President Jan 31 '24 Option Exercise 0.00 2,631 0 3,389 Feb 02 06:35 PM BONNER EIMEAR P Vice President Jan 31 '24 Option Exercise 0.00 2,164 0 6,778 Feb 02 06:35 PM HEARNE ANDREW NIGEL Executive Vice President Jan 31 '24 Option Exercise 0.00 5,453 0 13,455 Feb 02 06:47 PM GUSTAVSON JEFF B Vice President Jan 31 '24 Option Exercise 0.00 6,731 0 6,786 Feb 02 06:44 PM Wirth Michael K Chairman and CEO Jan 31 '24 Option Exercise 0.00 39,430 0 64,092 Feb 02 06:45 PM Pate R. Hewitt VP and General Counsel Jan 31 '24 Option Exercise 0.00 7,859 0 13,990 Feb 02 06:43 PM NELSON MARK A Vice Chairman Jan 31 '24 Option Exercise 0.00 10,529 0 19,370 Feb 02 06:39 PM Breber Pierre R VP & Chief Financial Officer Jan 31 '24 Option Exercise 0.00 10,423 0 16,563 Feb 02 06:39 PM GUSTAVSON JEFF B Vice President Dec 18 '23 Option Exercise 0.00 257 0 2,392 Dec 20 09:38 PM MORRIS RHONDA J Vice President Dec 18 '23 Option Exercise 0.00 183 0 4,176 Dec 20 09:36 PM Wirth Michael K Chairman and CEO Dec 18 '23 Option Exercise 0.00 1,442 0 26,104 Dec 20 09:30 PM Pate R. Hewitt VP and General Counsel Dec 18 '23 Option Exercise 0.00 315 0 6,446 Dec 20 09:29 PM HEARNE ANDREW NIGEL Executive Vice President Dec 18 '23 Option Exercise 0.00 745 0 8,278 Dec 20 09:28 PM Knowles Alana K VP and Controller Dec 18 '23 Option Exercise 0.00 81 0 1,473 Dec 20 09:27 PM NELSON MARK A Vice Chairman Dec 18 '23 Option Exercise 0.00 366 0 9,207 Dec 20 09:26 PM Breber Pierre R VP & Chief Financial Officer Dec 18 '23 Option Exercise 0.00 366 0 6,506 Dec 20 09:24 PM Breber Pierre R VP & Chief Financial Officer Aug 11 '23 Option Exercise 103.71 25,000 2,592,750 31,021 Aug 15 04:18 PM Breber Pierre R VP & Chief Financial Officer Aug 11 '23 Sale 164.00 25,000 4,100,000 6,021 Aug 15 04:18 PM GUSTAVSON JEFF B Vice President Aug 03 '23 Option Exercise 103.71 3,750 388,912 1,718 Aug 07 05:05 PM GUSTAVSON JEFF B Vice President Aug 03 '23 Sale 160.88 3,750 603,300 1,718 Aug 07 05:05 PM
Index S&P 500
P/E 16.93
EPS (ttm) 27.34
Insider Own 0.06%
Shs Outstand 240.00M
Perf Week -1.02%
Market Cap 111.04B
Forward P/E 16.58
EPS next Y 27.92
Insider Trans -13.20%
Shs Float 239.80M
Perf Month 1.63%
Income 6.78B
PEG 4.50
EPS next Q 6.45
Inst Own 76.22%
Short Float 0.95%
Perf Quarter 9.74%
Sales 69.64B
P/S 1.59
EPS this Y -5.54%
Inst Trans -0.78%
Short Ratio 2.00
Perf Half Y 1.03%
Book/sh 27.72
P/B 16.70
EPS next Y 6.24%
ROA 12.37%
Short Interest 2.27M
Perf Year 2.40%
Cash/sh 11.63
P/C 39.80
EPS next 5Y 3.76%
ROE 83.16%
52W Range 393.77 - 479.50
Perf YTD 2.10%
Dividend Est. 12.80 (2.77%)
P/FCF 17.86
EPS past 5Y 9.38%
ROI 26.16%
52W High -3.49%
Beta 0.47
Dividend TTM 12.30 (2.66%)
Quick Ratio 1.11
Sales past 5Y 4.79%
Gross Margin 12.18%
52W Low 17.53%
ATR (14) 6.24
Dividend Ex-Date Jun 03, 2024
Current Ratio 1.30
EPS Y/Y TTM 24.91%
Oper. Margin 12.18%
RSI (14) 58.62
Volatility 0.99% 1.46%
Employees 122000
Debt/Eq 2.92
Sales Y/Y TTM 5.28%
Profit Margin 9.73%
Recom 2.67
Target Price 491.05
Option/Short Yes / Yes
LT Debt/Eq 2.89
EPS Q/Q -3.19%
Payout 44.11%
Rel Volume 0.69
Prev Close 461.91
Sales Surprise 7.21%
EPS Surprise 8.77%
Sales Q/Q 13.68%
Earnings Apr 23 BMO
Avg Volume 1.13M
Price 462.78
SMA20 1.00%
SMA50 3.55%
SMA200 4.61%
Trades
Volume 796,391
Change 0.19%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-15-24 Upgrade
JP Morgan
Neutral → Overweight
$475 → $518
Oct-11-23 Initiated
UBS
Neutral
$470
Oct-04-23 Reiterated
Jefferies
Hold
$505 → $455
Sep-28-23 Initiated
Deutsche Bank
Hold
$435
Sep-18-23 Upgrade
Wells Fargo
Underweight → Equal Weight
$440
Jul-19-23 Reiterated
Susquehanna
Positive
$575 → $550
Jul-19-23 Reiterated
RBC Capital Mkts
Sector Perform
$500 → $475
Apr-12-23 Downgrade
Robert W. Baird
Outperform → Neutral
$513
Feb-07-23 Upgrade
Credit Suisse
Underperform → Outperform
$427 → $510
Jan-30-23 Upgrade
DZ Bank
Hold → Buy
$523
Jan-13-23 Downgrade
Goldman
Neutral → Sell
$388 → $332
Jan-06-23 Downgrade
Vertical Research
Buy → Hold
$491
Dec-15-22 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$506 → $542
Dec-08-22 Initiated
Citigroup
Buy
$546
Oct-19-22 Upgrade
Robert W. Baird
Neutral → Outperform
$513
Oct-12-22 Initiated
Credit Suisse
Underperform
$375
Oct-11-22 Initiated
Wolfe Research
Peer Perform
Sep-28-22 Downgrade
Wells Fargo
Equal Weight → Underweight
$415
Aug-30-22 Initiated
RBC Capital Mkts
Sector Perform
$460
Feb-28-22 Upgrade
Wolfe Research
Peer Perform → Outperform
Show Previous Ratings
May-06-24 11:45PM
(The Wall Street Journal)
04:51PM
12:50PM
May-05-24 03:59AM
May-04-24 05:03PM
01:21PM
Loading…
May-03-24 01:21PM
08:16AM
07:35AM
07:31AM
07:26AM
06:03AM
May-02-24 04:41PM
Apr-30-24 09:00AM
Apr-29-24 05:55AM
Apr-28-24 06:49PM
04:29PM
Loading…
04:29PM
08:00AM
Apr-27-24 07:07AM
06:19AM
Apr-26-24 11:15AM
06:15AM
01:04AM
Apr-25-24 06:48AM
06:18AM
Apr-24-24 12:29PM
11:33AM
11:22AM
10:53AM
09:25AM
08:11AM
03:10AM
Loading…
03:10AM
01:16AM
(Thomson Reuters StreetEvents)
Apr-23-24 09:38PM
03:30PM
12:45PM
12:24PM
12:21PM
(The Wall Street Journal)
11:53AM
11:28AM
09:30AM
09:22AM
09:01AM
08:51AM
08:37AM
08:28AM
07:54AM
07:35AM
(Associated Press Finance)
07:34AM
07:30AM
07:29AM
06:30AM
Apr-21-24 07:00AM
Apr-19-24 11:38AM
Apr-18-24 09:15AM
Apr-17-24 02:15PM
Apr-16-24 10:00AM
09:10AM
Apr-15-24 05:50PM
05:45PM
02:40PM
11:21AM
11:13AM
(Investor's Business Daily)
09:40AM
Apr-12-24 09:21AM
06:43AM
Apr-11-24 07:24PM
07:06PM
08:45AM
Apr-10-24 12:06PM
04:58AM
Apr-09-24 05:50PM
04:21PM
(Investor's Business Daily)
01:08PM
08:13AM
Apr-08-24 07:23AM
07:09AM
07:03AM
Apr-06-24 07:01PM
Apr-04-24 08:40AM
Apr-03-24 05:50PM
04:32PM
12:10PM
09:11AM
05:52AM
Apr-02-24 11:23AM
08:15AM
Apr-01-24 10:01AM
09:00AM
Mar-31-24 07:17PM
04:42PM
Mar-30-24 11:58PM
06:32AM
Mar-29-24 10:48PM
Mar-28-24 05:50PM
08:26AM
Mar-27-24 11:50AM
11:42AM
Mar-26-24 08:45AM
08:30AM
04:25AM
Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1912 and is headquartered in Bethesda, MD.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Ellis James O Jr Director Apr 01 '24 Option Exercise 0.00 366 0 566 Apr 03 06:31 PM GORDON ILENE S Director Apr 01 '24 Option Exercise 0.00 366 0 1,916 Apr 03 06:31 PM Hill Stephanie C. Pres. Rotary & Mission Systems Mar 06 '24 Sale 431.59 4,499 1,941,710 12,604 Mar 07 07:50 PM Ulmer Gregory M President Aeronautics Mar 05 '24 Sale 431.19 6,204 2,675,125 0 Mar 07 07:50 PM Lavan Maryanne SVP & General Counsel Mar 05 '24 Sale 434.39 4,022 1,747,313 0 Mar 07 07:50 PM Lightfoot Robert M JR President Space Mar 05 '24 Sale 433.59 511 221,632 0 Mar 07 07:50 PM St John Frank A Chief Operating Officer Mar 01 '24 Sale 425.35 6,648 2,827,766 0 Mar 05 06:38 PM Cahill Timothy S Pres. Missiles & Fire Control Feb 25 '24 Option Exercise 0.00 1,515 0 14,310 Feb 27 08:07 PM Hill Stephanie C. Pres. Rotary & Mission Systems Feb 25 '24 Option Exercise 0.00 3,359 0 21,116 Feb 27 08:07 PM St John Frank A Chief Operating Officer Feb 25 '24 Option Exercise 0.00 4,629 0 11,822 Feb 27 08:07 PM Ulmer Gregory M President Aeronautics Feb 25 '24 Option Exercise 0.00 3,380 0 9,483 Feb 27 08:07 PM Lavan Maryanne SVP & General Counsel Feb 25 '24 Option Exercise 0.00 2,981 0 7,583 Feb 27 08:07 PM Paul Harry Edward III Vice President & Controller Feb 25 '24 Option Exercise 0.00 592 0 2,871 Feb 27 08:07 PM Lightfoot Robert M JR President Space Feb 25 '24 Option Exercise 0.00 768 0 771 Feb 27 08:07 PM TAICLET JAMES D JR Chairman, President & CEO Feb 25 '24 Option Exercise 0.00 12,291 0 61,453 Feb 27 08:07 PM St John Frank A Chief Operating Officer Dec 08 '23 Option Exercise 0.00 110 0 218 Dec 12 08:57 PM Hill Stephanie C. Executive Vice President Dec 08 '23 Option Exercise 0.00 78 0 12,682 Dec 12 08:57 PM Ulmer Gregory M Executive Vice President Dec 08 '23 Option Exercise 0.00 67 0 1,017 Dec 12 08:58 PM Lavan Maryanne SVP & General Counsel Dec 08 '23 Option Exercise 0.00 71 0 100 Dec 12 08:57 PM Cahill Timothy S Executive Vice President Dec 08 '23 Option Exercise 0.00 48 0 10,524 Dec 12 08:57 PM St John Frank A Chief Operating Officer Jul 27 '23 Option Exercise 0.00 112 0 156 Jul 31 09:08 PM TAICLET JAMES D JR Chairman, President & CEO Jul 27 '23 Option Exercise 0.00 10,992 0 35,875 Jul 31 09:08 PM Donovan John Director Jul 19 '23 Buy 457.07 548 250,476 3,378 Jul 19 01:29 PM
Index DJIA, S&P 500
P/E 21.40
EPS (ttm) 6.94
Insider Own 0.16%
Shs Outstand 2.41B
Perf Week 1.20%
Market Cap 357.58B
Forward P/E 13.56
EPS next Y 10.96
Insider Trans -1.74%
Shs Float 2.40B
Perf Month -2.50%
Income 17.49B
PEG 4.09
EPS next Q 2.71
Inst Own 71.44%
Short Float 0.69%
Perf Quarter -4.63%
Sales 89.66B
P/S 3.99
EPS this Y 7.40%
Inst Trans -0.39%
Short Ratio 2.16
Perf Half Y -1.10%
Book/sh 29.09
P/B 5.11
EPS next Y 2.88%
ROA 9.15%
Short Interest 16.56M
Perf Year -8.36%
Cash/sh 10.89
P/C 13.64
EPS next 5Y 5.23%
ROE 23.91%
52W Range 143.13 - 175.97
Perf YTD -5.21%
Dividend Est. 4.81 (3.24%)
P/FCF 19.12
EPS past 5Y -0.27%
ROI 18.39%
52W High -15.57%
Beta 0.53
Dividend TTM 4.76 (3.20%)
Quick Ratio 0.94
Sales past 5Y 1.31%
Gross Margin 68.49%
52W Low 3.81%
ATR (14) 2.59
Dividend Ex-Date May 20, 2024
Current Ratio 1.17
EPS Y/Y TTM 44.66%
Oper. Margin 25.66%
RSI (14) 46.14
Volatility 1.90% 1.61%
Employees 131900
Debt/Eq 0.48
Sales Y/Y TTM -6.90%
Profit Margin 19.51%
Recom 2.22
Target Price 172.96
Option/Short Yes / Yes
LT Debt/Eq 0.36
EPS Q/Q 5231.80%
Payout 84.93%
Rel Volume 0.63
Prev Close 149.27
Sales Surprise -0.08%
EPS Surprise 2.04%
Sales Q/Q -13.55%
Earnings Apr 16 BMO
Avg Volume 7.65M
Price 148.58
SMA20 0.30%
SMA50 -3.68%
SMA200 -5.91%
Trades
Volume 5,042,757
Change -0.46%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-18-24 Upgrade
HSBC Securities
Hold → Buy
$170
Dec-13-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$170 → $163
Dec-01-23 Upgrade
UBS
Neutral → Buy
$167 → $180
Oct-05-23 Initiated
RBC Capital Mkts
Outperform
$178
Sep-06-23 Initiated
HSBC Securities
Hold
$175
May-30-23 Resumed
Citigroup
Buy
$185
Mar-29-23 Initiated
UBS
Neutral
$164
Mar-01-23 Initiated
Guggenheim
Neutral
$161
Nov-18-22 Initiated
Credit Suisse
Neutral
$170
Oct-18-22 Initiated
Barclays
Equal Weight
$175
Oct-14-22 Reiterated
BofA Securities
Neutral
$185 → $178
Jun-22-22 Initiated
Daiwa Securities
Outperform
May-23-22 Resumed
SVB Leerink
Outperform
$200
Apr-06-22 Resumed
Morgan Stanley
Equal-Weight
$173
Mar-16-22 Downgrade
Bernstein
Outperform → Mkt Perform
$180 → $183
Mar-02-22 Resumed
BofA Securities
Neutral
$185
Dec-17-21 Initiated
Goldman
Neutral
$161
Dec-15-21 Reiterated
Citigroup
Buy
$192 → $195
Sep-07-21 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$187
May-28-21 Resumed
Morgan Stanley
Overweight
$187
Show Previous Ratings
Today 01:04AM
May-06-24 04:10PM
04:05PM
02:50PM
02:30PM
02:06PM
Loading…
02:06PM
01:37PM
08:38AM
06:58AM
04:21AM
May-03-24 05:04PM
04:07PM
02:41PM
09:00AM
08:30AM
(Investor's Business Daily)
08:30AM
Loading…
08:30AM
05:00AM
May-02-24 12:20PM
06:51AM
(Pharmaceutical Technology)
03:01AM
(Pharmaceutical Technology)
01:04AM
May-01-24 04:26PM
04:11PM
04:00PM
03:57PM
03:48PM
03:02PM
02:17PM
02:17PM
01:53PM
01:25PM
Loading…
01:25PM
01:25PM
12:27PM
(The Wall Street Journal)
12:11PM
11:26AM
11:02AM
(Pharmaceutical Technology)
10:31AM
10:23AM
10:15AM
09:54AM
09:36AM
09:35AM
09:33AM
09:03AM
08:46AM
07:20AM
07:15AM
(Associated Press Finance)
06:34AM
06:30AM
06:30AM
05:21AM
Apr-30-24 09:42AM
07:17AM
06:01AM
Apr-29-24 05:52PM
05:07PM
12:53PM
10:23AM
10:03AM
08:00AM
Apr-28-24 06:54PM
08:45AM
07:17AM
04:20AM
Apr-27-24 09:15AM
08:48AM
07:45AM
06:38AM
06:00AM
Apr-26-24 06:00AM
06:00AM
Apr-25-24 12:22PM
(Pharmaceutical Technology)
Apr-24-24 07:27AM
06:10AM
05:25AM
03:02AM
Apr-23-24 06:21PM
Apr-22-24 04:30PM
11:10AM
09:00AM
05:32AM
Apr-21-24 10:39AM
08:39AM
07:22AM
Apr-19-24 08:50PM
11:00AM
10:47AM
08:50AM
07:47AM
07:26AM
05:00AM
Apr-18-24 09:46PM
06:33PM
05:23PM
04:52PM
08:15AM
Apr-17-24 08:17AM
03:01AM
Apr-16-24 05:45PM
05:09PM
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
REED JOHN C EVP, Innovative Medicine, R&D May 01 '24 Option Exercise 0.00 22,255 0 22,561 May 03 04:31 PM Broadhurst Vanessa EVP, Global Corp Affairs Mar 13 '24 Sale 162.16 8,891 1,441,765 15,043 Mar 13 04:36 PM JOHNSON & JOHNSON 10% Owner Feb 29 '24 Option Exercise 0.72 3,855 2,792 4,103,430 Mar 06 03:42 PM JOHNSON & JOHNSON 10% Owner Feb 16 '24 Sale 25.81 3,725 96,142 4,099,575 Mar 06 03:42 PM Decker Robert J VP Corporate Controller Feb 13 '24 Option Exercise 0.00 313 0 19,059 Feb 15 04:53 PM Broadhurst Vanessa EVP, Global Corp Affairs Feb 13 '24 Option Exercise 0.00 408 0 24,143 Feb 15 04:53 PM Forminard Elizabeth Executive VP, General Counsel Feb 13 '24 Option Exercise 0.00 651 0 8,576 Feb 15 04:53 PM Duato Joaquin CEO and Chairman of the Board Feb 13 '24 Option Exercise 0.00 3,470 0 364,809 Feb 15 04:53 PM Hait William See Remarks Feb 13 '24 Option Exercise 0.00 834 0 39,074 Feb 15 04:53 PM Fasolo Peter Exec VP, Chief HR Officer Feb 13 '24 Option Exercise 0.00 925 0 112,550 Feb 15 04:53 PM Schmid Timothy EVP, WW Chair, MedTech Feb 13 '24 Option Exercise 0.00 499 0 13,290 Feb 15 04:53 PM Swanson James D. EVP, CIO Feb 13 '24 Option Exercise 0.00 447 0 14,765 Feb 15 04:53 PM Taubert Jennifer L EVP, WWC. Innovative Medicine Feb 13 '24 Option Exercise 0.00 1,302 0 155,517 Feb 15 04:53 PM Wolk Joseph J Exec VP, CFO Feb 13 '24 Option Exercise 0.00 1,780 0 69,663 Feb 15 04:53 PM Wengel Kathryn E EVP, Chief TO and Risk Officer Feb 13 '24 Option Exercise 0.00 651 0 82,599 Feb 15 04:53 PM Decker Robert J VP Corporate Controller Feb 12 '24 Option Exercise 0.00 1,912 0 19,269 Feb 14 06:36 PM Duato Joaquin CEO and Chairman of the Board Feb 12 '24 Option Exercise 0.00 36,618 0 377,239 Feb 14 06:36 PM Taubert Jennifer L EVP, WWC. Innovative Medicine Feb 12 '24 Option Exercise 0.00 26,202 0 167,618 Feb 14 06:36 PM Forminard Elizabeth Executive VP, General Counsel Feb 12 '24 Option Exercise 0.00 2,859 0 8,959 Feb 14 06:36 PM Wolk Joseph J Exec VP, CFO Feb 12 '24 Option Exercise 0.00 25,835 0 78,699 Feb 14 06:36 PM Hait William See Remarks Feb 12 '24 Option Exercise 0.00 8,932 0 42,316 Feb 14 06:36 PM Broadhurst Vanessa EVP, Global Corp Affairs Feb 12 '24 Option Exercise 0.00 4,701 0 25,081 Feb 14 06:36 PM Wengel Kathryn E EVP, Chief TO and Risk Officer Feb 12 '24 Option Exercise 0.00 13,813 0 89,014 Feb 14 06:36 PM Schmid Timothy EVP, WW Chair, MedTech Feb 12 '24 Option Exercise 0.00 5,736 0 15,678 Feb 14 06:36 PM Swanson James D. EVP, CIO Feb 12 '24 Option Exercise 0.00 5,456 0 16,013 Feb 14 06:36 PM Fasolo Peter Exec VP, Chief HR Officer Feb 12 '24 Option Exercise 0.00 14,960 0 118,644 Feb 14 06:36 PM Duato Joaquin CEO and Chairman of the Board Feb 09 '24 Option Exercise 90.44 130,969 11,844,836 439,283 Feb 13 05:18 PM Taubert Jennifer L EVP, WW Chair, Pharmaceuticals Feb 09 '24 Option Exercise 90.44 59,397 5,371,865 200,813 Feb 12 07:25 PM Taubert Jennifer L EVP, WW Chair, Pharmaceuticals Feb 09 '24 Sale 156.27 59,397 9,281,969 141,416 Feb 12 07:25 PM Taubert Jennifer L EVP, WW Chair, Pharmaceuticals Feb 08 '24 Option Exercise 0.00 3,739 0 143,329 Feb 12 07:25 PM Decker Robert J VP Corporate Controller Feb 08 '24 Option Exercise 0.00 655 0 17,572 Feb 12 07:24 PM Broadhurst Vanessa EVP, Global Corp Affairs Feb 08 '24 Option Exercise 0.00 1,880 0 21,083 Feb 12 07:24 PM Hait William See Remarks Feb 08 '24 Option Exercise 0.00 3,059 0 34,497 Feb 12 07:24 PM Fasolo Peter Exec VP, Chief HR Officer Feb 08 '24 Option Exercise 0.00 2,135 0 104,465 Feb 12 07:24 PM Schmid Timothy EVP, WW Chair, MedTech Feb 08 '24 Option Exercise 0.00 1,964 0 10,943 Feb 12 07:24 PM Swanson James D. See Remarks Feb 08 '24 Option Exercise 0.00 1,868 0 11,111 Feb 12 07:24 PM Forminard Elizabeth Executive VP, General Counsel Feb 08 '24 Option Exercise 0.00 979 0 6,463 Feb 12 07:24 PM Wolk Joseph J Exec VP, CFO Feb 08 '24 Option Exercise 0.00 3,686 0 53,911 Feb 12 07:25 PM Wengel Kathryn E EVP, Chief TO and Risk Officer Feb 08 '24 Option Exercise 0.00 1,971 0 67,905 Feb 12 07:25 PM Duato Joaquin CEO and Chairman of the Board Feb 08 '24 Option Exercise 0.00 5,225 0 310,583 Feb 12 07:25 PM Hait William See Remarks Jul 26 '23 Option Exercise 90.44 14,698 1,329,287 102,445 Jul 27 05:52 PM Hait William See Remarks Jul 26 '23 Sale 172.00 14,698 2,528,056 87,747 Jul 27 05:52 PM Fasolo Peter Exec VP, Chief HR Officer Jul 25 '23 Sale 170.32 20,000 3,406,498 102,696 Jul 27 05:52 PM Wengel Kathryn E EVP, Chief TO and Risk Officer Jun 12 '23 Sale 160.00 12,465 1,994,400 65,934 Jun 14 04:19 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite